DHFR and neoplasm: High-dose Mtx (HDMtx) acts through inhibition of the dihydrofolate reductase (DHFR) enzyme with very high potency and hence blocks the purine synthesis in the s-phase of the cell cycle, thereby preventing cell proliferation in both tumor and normal cells.